Profile of:
Maria Sole Chimenti
Associate Professor in the Department of "Medicina dei Sistemi", Rheumatology, Allergology and Clinical Immunology Professor of Rheumatology at the Master of Science in Rehabilitation and at the Master of Physiotherapy, University of Rome “Tor Vergata”. Professor of Rheumatology at the course of Musculoskeletal diseases and Immunology and Allergology, Faculty of Medecine and Surgery, University of Rome Tor Vergata Professor of Rheumatology at the University "Nostra Signora del Buon Consiglio", Tirana, Albania. Author and co-author of 200 papers on peer-reviewed international journals; H-index: 38; Total number of citations 4170
Full name: Maria Sole Chimenti
Current country: Italy
Membership level: Associate
Type of membership: Member
Number of publications: 24
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis. (2024)
https://pubmed.ncbi.nlm.nih.gov/39076975/
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study. (2024)
https://pubmed.ncbi.nlm.nih.gov/39053949/
Psoriatic dactylitis: from immunopathogenesis to anti-cytokine and targeted synthetic therapies (2024)
https://pubmed.ncbi.nlm.nih.gov/39212137/
The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis. (2024)
https://pubmed.ncbi.nlm.nih.gov/39037828/
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? (2024)
https://pubmed.ncbi.nlm.nih.gov/39003339/
Editorial: New insights into spondyloarthritis: from bench to bedside. (2024)
https://pubmed.ncbi.nlm.nih.gov/38860027/
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy. (2024)
https://pubmed.ncbi.nlm.nih.gov/38761785/
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders. (2024)
https://pubmed.ncbi.nlm.nih.gov/38759215/
The steroid-sparing effect of JAK inhibitors across multiple patient populations. Front Immunol. (2024)
https://pubmed.ncbi.nlm.nih.gov/38680499/
Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis. (2024)
https://pubmed.ncbi.nlm.nih.gov/38523584/
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus. (2024)
https://pubmed.ncbi.nlm.nih.gov/38521214/
Pain in axial spondyloarthritis: role of the JAK/STAT pathway (2024)
https://pubmed.ncbi.nlm.nih.gov/38464510/
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases. (2024)
https://pubmed.ncbi.nlm.nih.gov/38296800/
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts. (2024)
https://pubmed.ncbi.nlm.nih.gov/38101911/
Osteoimmunology of Spondyloarthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/37834372/
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs (2023)
https://pubmed.ncbi.nlm.nih.gov/37650298/
Rheumatologist’s Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy (2023)
https://pubmed.ncbi.nlm.nih.gov/37298638/
Psoriatic Arthritis in Males and Females: Differences and Similarities. (2023)
https://pubmed.ncbi.nlm.nih.gov/36795290/
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management (2023)
https://pubmed.ncbi.nlm.nih.gov/36308677/
Micronutrients deficiencies in patients with spondylarthritis: the potential immunometabolic crosstalk in disease phenotype. (2022)
https://pubmed.ncbi.nlm.nih.gov/35363353/
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases. (2021)
https://pubmed.ncbi.nlm.nih.gov/32669448/
ex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients. (2021)
https://pubmed.ncbi.nlm.nih.gov/34876490/
Tackling the autoimmune side in Spondyloarthritis: A systematic review. (2020)
https://pubmed.ncbi.nlm.nih.gov/32801035/
Enteropathic spondyloarthritis: Results from a large nationwide database analysis. (2020)
https://pubmed.ncbi.nlm.nih.gov/31838160/